Intuitive Surgical, Inc. (BCBA:ISRG)
Argentina · Delayed Price · Currency is ARS | Market Cap | 198.68T -13.3% |
| Revenue (ttm) | 16.35T +20.7% |
| Net Income | 4.65T +20.4% |
| EPS | 12,919.53 +21.6% |
| Shares Out | n/a |
| PE Ratio | 42.73 |
| Forward PE | 32.56 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 6,922 |
| Open | 6,600.00 |
| Previous Close | 6,415.00 |
| Day's Range | 6,465.00 - 6,605.00 |
| 52-Week Range | 5,785.00 - 10,400.00 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 20, 2026 |
About Intuitive Surgical
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling,... [Read more]
Financial Performance
In 2025, Intuitive Surgical's revenue was $10.06 billion, an increase of 20.51% compared to the previous year's $8.35 billion. Earnings were $2.86 billion, an increase of 22.97%.
Financial numbers in USD Financial StatementsNews
Intuitive Surgical upgraded to Outperform from Perform at Oppenheimer
Oppenheimer upgraded Intuitive Surgical (ISRG) to Outperform from Perform.
Oppenheimer upgrades Intuitive Surgical on lack of U.S. competition
Oppenheimer upgraded Intuitive Surgical (ISRG) to Outperform from Perform with a $500 price target. Field checks suggest workflow challenges for Johnson & Johnson’s (JNJ) Ottava that limit long-term a...
Intuitive Surgical downgraded to Hold from Buy at HSBC
HSBC downgraded Intuitive Surgical (ISRG) to Hold from Buy with a $391 price target
Intuitive Surgical assumed with Buy from Neutral at UBS
UBS upgraded Intuitive Surgical (ISRG) to Buy from Neutral with a price target of $500, down from $550, after assuming coverage of the name. The firm views the recent selloff…
After industry event, Piper sees Intuitive Surgical as dominant player
After attending the Society of Robotic Surgery meeting, Piper Sandler sees “lots of greenfield ahead” for the soft tissue robotic category. While robot-assisted surgery competition is increasing with ...
Intuitive Collaborates with Deion “Coach Prime” Sanders to Raise Patient Awareness of Surgical Options
Intuitive today announced a collaboration with Deion “Coach Prime” Sanders to help increase patient awareness and understanding of surgical options.
Intuitive Shares Vision for an AI-Enabled Future of Healthcare
SUNNYVALE, Calif., July 23, 2026 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, will outline its visio...
ISRG’s Post-Earnings Plunge Opens Up an Opportunity
The post-earnings plunge in Intuitive Surgical ($ISRG) opens up an opportunity for the bulls after a report that was far better than the share-price reaction suggests. Investors seized on slower…
Why Intuitive Surgical Stock Plunged Today
Intuitive Surgical (ISRG) shares plummeted Friday after the maker of robotic surgical tools failed to raise the outlook for its flagship product despite better-than-expected second-quarter results.
Intuitive Surgical falls -12.5%
Intuitive Surgical (ISRG) is down -12.5%, or -$50.34 to $352.00.
Intuitive Surgical price target lowered to $470 from $515 at BofA
BofA lowered the firm’s price target on Intuitive Surgical (ISRG) to $470 from $515 and keeps a Buy rating on the shares. Intuitive now expects FY26 worldwide procedure growth to…
Friday's Morning Movers: SPCX Scrubs Test Flights, AAPL Upgrade, ISRG Earnings
Diane King Hall discusses Intuitive Surgical (ISRG) earnings, explaining how GLP-1 trends have hit the company. She also talks about SpaceX (SPCX) shares coming back to Earth after scrubbing Starship'...
Intuitive Surgical falls -10.7%
Intuitive Surgical (ISRG) is down -10.7%, or -$42.92 to $359.41.
Intuitive Surgical falls as Obamacare concerns rekindle medtech demand debate
Intuitive Surgical shares fell more than 12% before the bell on Friday after it maintained its global growth forecast for procedures performed with its da Vinci surgical robots and warned that change...
Intuitive Surgical stock sinks despite earnings beat on 2026 procedure growth outlook
Shares of Intuitive Surgical tumbled about 12% in premarket trading on Friday after the robotic surgery company issued a full-year procedure growth outlook that fell short of investor expectations, ov...
Intuitive Surgical beats quarterly estimates on strong demand for its robotic systems
Intuitive Surgical on Thursday maintained its 2026 forecast for worldwide growth in procedures assisted by its cutting-edge da Vinci robots, after beating Wall Street estimates for second-quarter pr...
Intuitive Surgical Earnings Call Transcript: Q2 2026
Q2 delivered strong revenue and procedure growth, driven by robust adoption of da Vinci 5, SP, and Ion platforms. Guidance for 2026 remains positive, with continued innovation, stable capital demand, and expanding access in cost-sensitive markets.
Intuitive Surgical Earnings release: Q2 2026
Intuitive Surgical released its Q2 2026 earnings on July 16, 2026, summarizing the period's financial results.
Intuitive Surgical Slides: Q2 2026
Intuitive Surgical has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 16, 2026.
Intuitive Surgical Quarterly report: Q2 2026
Intuitive Surgical has published its Q2 2026 quarterly earnings report on July 16, 2026.
Intuitive Announces Second Quarter Earnings
SUNNYVALE, Calif., July 16, 2026 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today ...
Intuitive Announces New Chief Commercial and Marketing Officer Taylor Patton
Current Chief Commercial and Marketing Officer Henry Charlton to become SVP of Global Business Operations Current Chief Commercial and Marketing Officer Henry Charlton to become SVP of Global Business...
Intuitive Announces Innovations to Advance Quintuple Aim
Latest innovations include enhanced telecollaboration capabilities, extended uses for Force Feedback technology, and advancements in product and instrument reliability and security Latest innovations ...
AI, Obesity Drugs, and Diagnostics Fuel Healthcare Growth
Healthcare is regaining momentum as innovation—especially AI‑driven drug discovery—creates new growth opportunities, according to Shivani Vohra. She points to obesity treatments from Eli Lilly (LLY) a...